# Codex Review: medical_monitoring_p7c_20260729

Date: 2026-07-29
Execution: delegated implementation with Codex conflict-point review and final acceptance

## Verdict

Pass for the P7C implementation contract. Operational production qualification
remains blocked by absent real authoritative evidence, as required.

## Boundary Check

- Product edits are limited to the four contract-authorized backend files.
- Test edits are limited to P7C and directly adjacent lifecycle/API/real-listing
  expectations invalidated by the new release gate.
- Records are limited to P7C context, metrics, review, and handoff surfaces.
- No frontend, medical-writing, shared-AI, runtime database, current API route,
  or P7B record-resolution implementation was changed.

## Codex Verification

- Re-read final model, repository, service, authority and cross-project family
  qualification paths after delegated implementation.
- Verified stable ID/hash participation for labels and diagnostic content.
- Verified publication revalidation uses repository sets rather than caller
  coverage counts.
- Challenged and rejected the initial family gate because a second project with
  only one negative case was being counted as authoritative.
- Verified the corrected implementation groups by exact rule revision and
  requires positive, negative, boundary and diagnostic coverage from the same
  revision before counting a project.
- Codex independently ran the focused authority/lifecycle combination:
  `89 passed`.
- The delegated implementation run reported `119 passed` in focused/adjacent
  tests and `644 passed` in the full medical-monitoring suite; these are retained
  as delegated execution evidence, not mislabeled as Codex direct execution.

## Contract Review

- Every contract-named negative gate has a dedicated test.
- Family project qualification now groups by exact rule revision and requires
  positive, negative, boundary, and diagnostic evidence from the same revision.
  A negative-only second project and a source-invalid complete second project
  are both excluded.
- The real-listing test was corrected to treat existing RUX/MY009 rows as
  candidates, not production release evidence.
- CM versus EX/EC/DA/IP is enforced by closed domain compatibility tests.
- J07 alone has a negative non-inference test.
- No claim is made that two real projects currently satisfy the gate.

## Residual Risk

- Real RUX/MG-K10 mapping, batch freeze, protocol applicability, and medical case
  confirmation remain future operational work.
- Explicit P7C case authoring is not exposed through the unchanged current API.
- The two new laboratory/CTCAE rule families are accepted by the core model but
  intentionally do not imply template catalogue entries.
- Cross-project family qualification is a frozen evidence gate. It does not
  claim a second project's shadow execution passed; execution remains enforced
  by each publishing project's complete repository shadow run. Adding the
  current run as its own prerequisite would create a stable-ID/hash persistence
  cycle.
